
BellaSeno ramps up human trials of regenerative breast scaffolds after Johnson & Johnson partnerhsip
Clinical-stage medtech BellaSeno, a company founded in Australia and now based in Germany, is ramping up human trials of its proprietary absorbable breast scaffolds, with 30 Australian women having undergone scaffold surgery across two clinical trials as the company pushes toward commercialisation of what it describes as a new approach to s...